PATENT CLAIM ANALYSIS

Application Number: 16292473
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "561000"]

Abstract:
A method for relieving menstrual pain and reducing menstrual blood loss in a female is provided. The method comprises administering to the female an oral combination drug formulation comprising a first therapeutically effective dose of a non-steroidal anti-inflammatory drug (NSAID) and a second complementary low dose of tranexamic acid, wherein the NSAID is formulated to relieve the menstrual pain and to reduce a volume of menstrual blood loss of the female, wherein the dose of tranexamic acid ranges from 50 mg to 425 mg per oral combination drug formulation.

Claim (Index 19):
The composition of  claim 16 , wherein the NSAID comprises any one of: ibuprofen, naproxen, diclofenac, ketoprofen, mefenamic acid, and metabolites thereof.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 99.0
- Lexical Diversity: 1.75926
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12714181', '12433510', '13016800', '13230902', '14017530']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7876121395508641
- 35 USC 102 Novelty (BERT): 0.5411133818230738
- Combined Prediction Score: 0.7629622637780851
- Mean Citation Score: 351.910706
- Max Citation Score: 386.66403
- Similarity Product: 286.1317085451257

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test